Stock Market
Watch
×
Search
Home
Markets
Stock Market Today
SP500
Dow Jones
Nasdaq
NYSE
AMEX
Forex
Movers
PreMarket
Top Movers
After Hours
PreMarket
Watchlists
Crypto
Metals
Metal Prices
Gold Price
Silver Price
Copper Price
Platinum Price
Palladium Price
Learn
VSTM Stock Price Today
Add to Watchlist
Quote
Premarket
Analysts
Insiders
Financials
Earnings
Filings
Profile
Historical
Performance
VSTM Stock Quote and Chart
Track all markets on TradingView
VSTM News
Verastem: The Market Is Ignoring The Progress | $VSTM
Verastem’s avutometinib combination shows 31% ORR in ovarian cancer trial
The response rate was higher in those with a KRAS mutation at 44%, compared to 17% in KRAS wild-type...
Verastem stock rises after LGSOC treatment data published in medical journal
Verastem's cancer drug shows 31% response rate in ovarian cancer trial
Verastem Oncology Announces Publication of the Primary Results from the Phase 2 RAMP 201 Trial of Avutometinib in Combination with Defactinib in Patients with Recurrent Low-Grade Serous Ovarian Cancer in the Journal of Clinical Oncology
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to ...
VSTM Financials
Track all markets on TradingView
VSTM Tech Analysis
Track all markets on TradingView
VSTM Profile
Track all markets on TradingView